Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/06/2000 | EP1056842A2 Genetic vaccine vector engineering |
12/06/2000 | EP1056838A1 Method for the development of an hiv vaccine |
12/06/2000 | EP1056836A2 Submucosa gel compositions |
12/06/2000 | EP1056835A1 Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies |
12/06/2000 | EP1056834A2 Apoptotic cell-mediated antigen presentation to dendritic cells |
12/06/2000 | EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
12/06/2000 | EP1056777A1 Ligand receptors and uses therefor |
12/06/2000 | EP1056764A1 Secreted proteins and polynucleotides encoding them |
12/06/2000 | EP1056762A1 Genetic immunization with nonstructural proteins of hepatitis c virus |
12/06/2000 | EP1056760A1 36 human secreted proteins |
12/06/2000 | EP1056468A1 Method of promoting embryonic stem cell proliferation |
12/06/2000 | EP1056336A1 Selection of mature sperm by surface membrane determinants |
12/06/2000 | EP1056334A1 A method for the production of transgenic plants using apical shoot tips |
12/06/2000 | EP0968224A4 Chimeric mutational vectors having non-natural nucleotides |
12/06/2000 | EP0801657A4 Retinoid x receptor-interacting polypeptides and related molecules and methods |
12/06/2000 | EP0729506A4 Myocardial grafts and cellular compositions useful for same |
12/06/2000 | EP0707634B1 Stromal cell lines from human bone marrow and their use |
12/06/2000 | CN1276012A Methods of producing protein hydrolysates |
12/06/2000 | CN1275885A Precise efficary assay methods for active agents including chemotherapeutic agents |
12/06/2000 | CN1275618A Method for cultivating T-lymphocytes |
12/06/2000 | CN1059214C Cellulose binding domain |
12/05/2000 | US6156954 Receptor-like protein kinase, RKN, and method of use for increasing growth and yield in plants |
12/05/2000 | US6156888 Mixture of a carrier and a polynucleotide encoding a hybrid protein of a factor viii protein having an acidic region from a donor anticoagulant or antithrombotic protein replacing a region in the native protein |
12/05/2000 | US6156887 Compositions and methods for the treatment and diagnosis of immune disorders |
12/05/2000 | US6156883 Hybridoma for production of high affinity monoclonal antibodies |
12/05/2000 | US6156881 Inhibition of cell adhesion protein-carbohydrate interactions |
12/05/2000 | US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders |
12/05/2000 | US6156877 Receptor for interleukin-4; has molecular weight of about 200,000 daltons; antitumor agents; immunosuppressants; antibodies |
12/05/2000 | US6156736 Gene transcription and ionizing radiation: methods and compositions |
12/05/2000 | US6156725 Drug for the treatment of cancer |
12/05/2000 | US6156573 Hybrid Bacillus thuringiensis δ-endotoxins with novel broad-spectrum insecticidal activity |
12/05/2000 | US6156570 Process for the continuous culture of cells |
12/05/2000 | US6156569 Prolonged culturing of avian primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians |
12/05/2000 | US6156566 In vitro fertilization procedure dish |
12/05/2000 | US6156558 Alphavirus RNA replicon systems |
12/05/2000 | US6156554 Amino acid sequence; for recombinant production of enzyme and efficient industrial production of peptides |
12/05/2000 | US6156542 Preparing raw cytokines; purifying leukocytes, culture leukocytes, adjust heat, incubate with cytokine, incubate with sendai virus, lower heat, incubate with sendai virus and separate leukocytes from cytokines |
12/05/2000 | US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect |
12/05/2000 | US6156523 Serine/threonine protein kinases |
12/05/2000 | US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors |
12/05/2000 | US6156517 RNA binding protein and binding site useful for expression of recombinant molecules |
12/05/2000 | US6156516 Method for screening substance inhibiting activation of NF-κB |
12/05/2000 | US6156514 Methods for making recombinant cells |
12/05/2000 | US6156509 Method of increasing efficiency of directed evolution of a gene using phagemid |
12/05/2000 | US6156498 Establishment of HHV-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting HHV-8 infection |
12/05/2000 | US6156497 Hybrid plasmids for the expression of heterologous proteins and irreversible genetic adjustment to tissues |
12/05/2000 | US6156317 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
12/05/2000 | US6156307 Immortalization of dendritic cells with v-myc oncogene |
12/05/2000 | US6156306 Administering nucleic acid encoding adenovirus; genetic engineering |
12/05/2000 | CA2199843C Novel pka-binding proteins and uses thereof |
12/05/2000 | CA2146150C Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
12/05/2000 | CA2068644C Genetic control of ethylene biosynthesis in plants |
12/05/2000 | CA1341149C Insulin receptor |
11/30/2000 | WO2000072022A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
11/30/2000 | WO2000072021A2 Cancer associated antigens and uses therefor |
11/30/2000 | WO2000072010A1 Use of an antibody to detect basophiles and/or mast cells |
11/30/2000 | WO2000071752A2 Assay for the detection of paclitaxel resistant cells in human tumors |
11/30/2000 | WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
11/30/2000 | WO2000071737A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
11/30/2000 | WO2000071736A1 Isoflavonoid methylation enzyme |
11/30/2000 | WO2000071734A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
11/30/2000 | WO2000071728A1 Recombinant bacterial phytases and uses thereof |
11/30/2000 | WO2000071723A2 Methods for regulating protein conformation using molecular chaperones |
11/30/2000 | WO2000071720A1 Il-1 eta dna and polypeptides |
11/30/2000 | WO2000071710A2 Expression products of genes involved in diseases related to cholesterol metabolism |
11/30/2000 | WO2000071702A1 Interaction-activated proteins |
11/30/2000 | WO2000071695A1 Novel phytochelatin synthases and uses therefor |
11/30/2000 | WO2000071693A2 Method for selecting improved vectors |
11/30/2000 | WO2000071679A2 Human oxidoreductase proteins |
11/30/2000 | WO2000071678A1 Inducible packaging cell lines for lentivirus vectors |
11/30/2000 | WO2000071677A1 Method for providing a substrate structure for oriented neurite outgrowth, substrate structure, and device for monitoring neurons |
11/30/2000 | WO2000071670A2 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
11/30/2000 | WO2000071585A1 Human antibodies to staphylococcus aureus |
11/30/2000 | WO2000071584A1 Seven transmembrane receptor genes |
11/30/2000 | WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides |
11/30/2000 | WO2000071575A1 Models of prion disease |
11/30/2000 | WO2000071573A2 Immunogenic peptides derived from mage and the use thereof |
11/30/2000 | WO2000071566A2 Novel organic anion transport proteins |
11/30/2000 | WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
11/30/2000 | WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
11/30/2000 | WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes |
11/30/2000 | WO2000071158A1 Tagged epitope protein transposable element |
11/30/2000 | WO2000071157A2 New vaccine formulations - 1 |
11/30/2000 | WO2000071155A2 New vaccine formulations - 2 |
11/30/2000 | WO2000071150A1 Tumor necrosis factor receptor 5 |
11/30/2000 | WO2000071148A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin |
11/30/2000 | WO2000071136A1 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
11/30/2000 | WO2000050607A3 Goodpasture antigen binding protein |
11/30/2000 | WO2000047750A3 Metalloproteases of the neprilysin family |
11/30/2000 | WO2000047719A3 Maturation of dendritic cells with immune response modifying compounds |
11/30/2000 | WO2000046378A3 Method of improving the primary energy metabolism of mammalian cell lines |
11/30/2000 | WO2000044900A3 Nucleic-acid binding proteins |
11/30/2000 | WO2000043790A3 Compositions and methods for the diagnosis and treatment of tumor |
11/30/2000 | WO2000043525A3 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
11/30/2000 | WO2000043499A3 ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD |
11/30/2000 | WO2000042207A3 Soybean transformation method |
11/30/2000 | WO2000042201A3 Human peptidases |
11/30/2000 | WO2000042188A3 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
11/30/2000 | WO2000042172A3 Human homologues of proteins regulated by circadian rhythms |
11/30/2000 | WO2000042072A3 Polypeptide variants with altered effector function |